Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

64 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study.
Ozols RF, Bundy BN, Greer BE, Fowler JM, Clarke-Pearson D, Burger RA, Mannel RS, DeGeest K, Hartenbach EM, Baergen R. Ozols RF, et al. Among authors: degeest k. J Clin Oncol. 2023 Sep 1;41(25):4077-4083. doi: 10.1200/JCO.22.02766. J Clin Oncol. 2023. PMID: 37643542 Clinical Trial.
The addition of paclitaxel to doxorubicin and cisplatin and volume-directed radiation does not improve overall survival (OS) or long-term recurrence-free survival (RFS) in advanced endometrial cancer (EC): A randomized phase III NRG/Gynecologic Oncology Group (GOG) study.
Spirtos NM, Enserro D, Homesley HD, Gibbons SK, Cella D, Morris RT, DeGeest K, Lee RB, Miller DS. Spirtos NM, et al. Among authors: degeest k. Gynecol Oncol. 2019 Jul;154(1):13-21. doi: 10.1016/j.ygyno.2019.03.240. Epub 2019 Apr 30. Gynecol Oncol. 2019. PMID: 31053405 Free PMC article. Clinical Trial.
SSRI use and clinical outcomes in epithelial ovarian cancer.
Christensen DK, Armaiz-Pena GN, Ramirez E, Matsuo K, Zimmerman B, Zand B, Shinn E, Goodheart MJ, Bender D, Thaker PH, Ahmed A, Penedo FJ, DeGeest K, Mendez L, Domann F, Sood AK, Lutgendorf SK. Christensen DK, et al. Among authors: degeest k. Oncotarget. 2016 May 31;7(22):33179-91. doi: 10.18632/oncotarget.8891. Oncotarget. 2016. PMID: 27121207 Free PMC article.
Diurnal cortisol and survival in epithelial ovarian cancer.
Schrepf A, Thaker PH, Goodheart MJ, Bender D, Slavich GM, Dahmoush L, Penedo F, DeGeest K, Mendez L, Lubaroff DM, Cole SW, Sood AK, Lutgendorf SK. Schrepf A, et al. Among authors: degeest k. Psychoneuroendocrinology. 2015 Mar;53:256-67. doi: 10.1016/j.psyneuen.2015.01.010. Epub 2015 Jan 20. Psychoneuroendocrinology. 2015. PMID: 25647344 Free PMC article.
Focal adhesion kinase: an alternative focus for anti-angiogenesis therapy in ovarian cancer.
Stone RL, Baggerly KA, Armaiz-Pena GN, Kang Y, Sanguino AM, Thanapprapasr D, Dalton HJ, Bottsford-Miller J, Zand B, Akbani R, Diao L, Nick AM, DeGeest K, Lopez-Berestein G, Coleman RL, Lutgendorf S, Sood AK. Stone RL, et al. Among authors: degeest k. Cancer Biol Ther. 2014 Jul;15(7):919-29. doi: 10.4161/cbt.28882. Epub 2014 Apr 23. Cancer Biol Ther. 2014. PMID: 24755674 Free PMC article.
Cortisol and inflammatory processes in ovarian cancer patients following primary treatment: relationships with depression, fatigue, and disability.
Schrepf A, Clevenger L, Christensen D, DeGeest K, Bender D, Ahmed A, Goodheart MJ, Dahmoush L, Penedo F, Lucci JA 3rd, Ganjei-Azar P, Mendez L, Markon K, Lubaroff DM, Thaker PH, Slavich GM, Sood AK, Lutgendorf SK. Schrepf A, et al. Among authors: degeest k. Brain Behav Immun. 2013 Mar;30 Suppl(0):S126-34. doi: 10.1016/j.bbi.2012.07.022. Epub 2012 Aug 5. Brain Behav Immun. 2013. PMID: 22884960 Free PMC article.
64 results